Advisory Resource Group Royalty Pharma PLC Transaction History

Advisory Resource Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 17, 2024	BUY	$27.46 - $31.33 $744,742 - $849,700	27,121 New	27,121 $823,000
Q2 2022 Jul 21, 2022	BUY	$37.53 - $44.22 $1.91 Million - $2.25 Million	50,833 Added 472.07%	61,601 $2.59 Million
Q1 2022 Apr 06, 2022	BUY	$37.46 - $42.44 $40,157 - $45,495	1,072 Added 11.06%	10,768 $420,000
Q4 2021 Feb 08, 2022	BUY	$35.17 - $42.48 $341,008 - $411,886	9,696 New	9,696 $388,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Advisory Resource Group, based on Form 13F filings with the SEC.

Stay updated on Advisory Resource Group with notifications on news.